Metastasis from Malignant Tumor of Liver clinical trials at UCSF
1 research study open to eligible people
Metastasis from a malignant liver tumor is the spread of liver cancer cells to other areas. UCSF is running trials to investigate innovative treatments for advanced cancers. These trials are assessing how NBTXR3 activated by radiotherapy works with anti-PD-1 therapies.
Showing trials for
NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD-1 Therapy
open to eligible people ages 18 years and up
The 1100 study is an open-label, Phase I, dose escalation and expansion prospective clinical study to assess the safety of intratumoral injection of NBTXR3 activated by radiotherapy in combination with anti-PD-1 therapy.
San Francisco, California and other locations
Our lead scientists for Metastasis from Malignant Tumor of Liver research studies include Jason Chan.
Last updated: